(Q40485390)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7680643%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

review article

1 reference

title

Treatment of therapy-related leukemia and myelodysplastic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7680643%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

author name string

Kantarjian HM

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7680643%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Estey EH

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7680643%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Keating MJ

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7680643%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

publication date

1 February 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7680643%20AND%20SRC:MED&resulttype=core&format=json

Hematology / Oncology Clinics of North America

23 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7680643%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7680643%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

81-107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7680643%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7680643%20AND%20SRC:MED&resulttype=core&format=json

Therapy-related preleukemic syndrome

23 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Post-therapeutic acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Glucocorticoid therapy in the preleukemic syndrome (hemopoietic dysplasia): identification of responsive patients using in-vitro techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Bone marrow transplantation for myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Partially matched bone marrow transplantation in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Acute nonlymphocytic leukemia.A delayed complication of Hodgkin's disease therapy: Analysis of 109 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

The myelodysplastic syndromes: current approaches to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Preleukemic changes in cases of nonlymphocytic leukemia secondary to cytotoxic therapy. Analysis of 105 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Chromosomal localization of the human proto-oncogene c-ets

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Allogeneic bone marrow transplantation in a patient with acute myeloid leukemia secondary to Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Response of therapy-associated acute nonlymphocytic leukemia to intensive induction chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Acute leukemia after chemotherapy (melphalan)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Aggressive chemotherapy in adult primary myelodysplastic syndromes. A report on 29 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Therapy-related leukemia. A panmyelosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Alpha-interferon in myelodysplasia; clinical observations and effects on NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Localization of an ataxia-telangiectasia gene to chromosome 11q22-23.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Melphalan may be a more potent leukemogen than cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Mature T-lineage leukemia with growth factor-induced multilineage differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Acute myeloid leukemia following treatment of Hodgkin's disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Radiation carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Phase I study of recombinant human interleukin-3 in patients with bone marrow failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

13-cis-Retinoic acid treatment in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

The myelodysplastic syndromes: biology and implications for management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Therapeutic efficacy of danazol in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Retinoblastoma: Clues to Human Oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Refractory anemia with excess of blast cells: prognostic factors and effect of treatment with androgens or cytosine arabinoside. Results of a prospective trial in 58 patients. Cooperative Group for the Study of Aplastic and Refractory Anemias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Localization of the human NCAM gene to band q23 of chromosome 11: the third gene coding for a cell interaction molecule mapped to the distal portion of the long arm of chromosome 11

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Expression of the human c-fms proto-oncogene in hematopoietic cells and its deletion in the 5q- syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agent

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

13-cis retinoic acid treatment for myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Therapy of secondary acute nonlymphocytic leukemia with cytarabine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

erg, a human ets-related gene on chromosome 21: alternative splicing, polyadenylation, and translation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Cytogenetic and molecular analysis of therapy-related leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Bone marrow transplantation performed as first-time treatment in two cases of secondary acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Second acute leukemia and other malignancies following treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Chromosomal localization of the human Thy-1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Effective chemotherapy of acute myelocytic leukemia occurring after alkylating agent or radiation therapy for prior malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Translocation (9;11)(p21;q23) in a child with acute monoblastic leukemia following 2 1/2 years after successful chemotherapy for neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Antiviral and anticellular activities of human and murine type I and type II interferons in human cells monosomic, disomic, and trisomic for chromosome 21

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930259-4

7 January 2021

10.1016/S0889-8588(18)30259-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7680643%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference